Monsanto and Dow AgroSciences Announce Global Licensing Agreement on EXZACT Precision Technology Genome-Editing Platform
October 03 2016 - 12:00PM
Business Wire
Monsanto Company (NYSE: MON) and Dow AgroSciences LLC, a
wholly-owned subsidiary of The Dow Chemical Company (NYSE: DOW),
announced today that the companies have reached a non-exclusive
global option and licensing agreement on Dow AgroSciences’ EXZACT™
Precision Technology® Platform for research and commercial
development of new crop solutions across Monsanto Company’s
research portfolio.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20161003006028/en/
EXZACT technology, which Dow AgroSciences has developed under an
exclusive license and collaboration agreement in plants with
Sangamo BioSciences, Inc., facilitates the creation of crop
varieties and lines having improved traits.
“Monsanto is pleased to pursue applications of this
genome-editing technology for the development of new plant
discoveries and solutions for farmers,” said Tom Adams, Ph.D.,
biotechnology lead for Monsanto. “Zinc finger nucleases are a
well-established technology for gene editing and this license,
together with our existing and other licensed technology, will
allow us to pursue product development while further enabling our
growing body of research in this emerging field.”
“EXZACT technology is helping to deliver next generation crop
improvements into the hands of farmers,” said Daniel R. Kittle,
Ph.D., vice president, research and development, Dow AgroSciences.
“Broad adoption of EXZACT by industry partners, such as Monsanto,
expands access to solutions that will improve grower productivity
and profitability.”
Both companies noted that genome-editing technology and the
broad array of emerging genome-editing techniques, including the
zinc finger nuclease (ZFN) technology in EXZACT, represent key
scientific applications that can deliver breakthroughs in
agriculture. Monsanto believes that genome-editing technologies
will enable plant breeders to deliver better hybrids and varieties
more efficiently, as well as offer plant scientists additional
resources to provide new improvements in plant biotechnology.
Additional terms of the agreement were not disclosed.
About Monsanto Company
Monsanto is committed to bringing a broad range of solutions to
help nourish our growing world. We produce seeds for fruits,
vegetables and key crops – such as corn, soybeans, and cotton –
that help farmers have better harvests while using water and other
important resources more efficiently. We work to find sustainable
solutions for soil health, help farmers use data to improve farming
practices and conserve natural resources, and provide crop
protection products to minimize damage from pests and disease.
Through programs and partnerships, we collaborate with farmers,
researchers, nonprofit organizations, universities and others to
help tackle some of the world’s biggest challenges. To learn more
about Monsanto, our commitments and our more than 20,000 dedicated
employees, please visit: discover.monsanto.com and
monsanto.com. Follow our business on Twitter® at
twitter.com/MonsantoCo, on the company blog, Beyond the
Rows® at monsantoblog.com or subscribe to our News Release RSS
Feed.
About Dow AgroSciences
Dow AgroSciences discovers, develops, and brings to market crop
protection and plant biotechnology solutions for the growing world.
Based in Indianapolis, Indiana, USA, Dow AgroSciences is a wholly
owned subsidiary of The Dow Chemical Company and had annual global
sales of $6.4 billion in 2015. Learn more at www.dowagro.com.
Follow Dow AgroSciences on Facebook, Twitter, LinkedIn, and
Google+, or subscribe to our News Release RSS Feed.
®™Trademark of The Dow Chemical Company (“Dow”) or an affiliated
company of Dow.
Cautionary Statements Regarding Forward-Looking
Information
Certain statements contained in this release are
“forward-looking statements,” such as statements concerning the
company’s anticipated financial results, current and future product
performance, regulatory approvals, business and financial plans and
other non-historical facts, as well as the proposed transaction
with Bayer Aktiengesellschaft (“Bayer”). These statements are based
on current expectations and currently available information.
However, since these statements are based on factors that involve
risks and uncertainties, the company’s actual performance and
results may differ materially from those described or implied by
such forward-looking statements. Factors that could cause or
contribute to such differences include, among others: risks related
to the proposed transaction between the company and Bayer,
including the risk that the company’s shareowners do not approve
the transaction, the risk that the regulatory approvals required
for the transaction may not be obtained on the anticipated terms or
time frame or at all, the risk that the other conditions to the
completion of the transaction may not be satisfied, the risk that
disruptions or uncertainties related to the proposed transaction
could adversely affect the company’s business, financial
performance and/or relationships with third parties, and the risk
that certain contractual restrictions during the pendency of the
transaction could adversely affect the company’s ability to pursue
business opportunities or strategic transactions; continued
competition in seeds, traits and agricultural chemicals; the
company’s exposure to various contingencies, including those
related to intellectual property protection, regulatory compliance
and the speed with which approvals are received, and public
understanding and acceptance of our biotechnology and other
agricultural products; the success of the company’s research and
development activities; the outcomes of major lawsuits, including
potential litigation related to the proposed transaction with
Bayer; developments related to foreign currencies and economies;
fluctuations in commodity prices; compliance with regulations
affecting our manufacturing; the accuracy of the company’s
estimates related to distribution inventory levels; the recent
increases in levels of indebtedness, continued availability of
capital and financing and rating agency actions; the company’s
ability to fund its short-term financing needs and to obtain
payment for the products that it sells; the effect of weather
conditions, natural disasters, accidents, and security breaches,
including cybersecurity incidents, on the agriculture business or
the company’s facilities; and other risks and factors detailed in
the company’s most recent periodic report to the SEC. Undue
reliance should not be placed on these forward-looking statements,
which are current only as of the date of this release. The company
disclaims any current intention or obligation to update any
forward-looking statements or any of the factors that may affect
actual results.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161003006028/en/
MonsantoMedia:Camille Scott,
314-694-4645orInvestors:Laura Meyer, 314-694-8148orDow
AgroSciencesMedia:Kenda Resler Friend,
317-337-4743orInvestors:Neal Sheorey, 989-636-6347
Dow (NYSE:DOW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dow (NYSE:DOW)
Historical Stock Chart
From Apr 2023 to Apr 2024